Verorab vaccine
Sponsors
African Malaria Network Trust, Vac4All
Conditions
Malaria
Phase 1
Phase 2
Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine
NCT00652275
Start: 2008-05-31End: 2010-12-31Target: 378Updated: 2008-05-07
Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in Africa
CompletedNCT01341704
Start: 2011-05-31End: 2013-03-31Updated: 2015-08-31